Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin-Reference-Cited by-同舟云学术

Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin

Published:2023-03-27 Issue:2 Volume:7 Page:136-141
ISSN:2432-261X
Container-title:Spine Surgery and Related Research
language:en
Short-container-title:Spine Surg Relat Res

Author:

Yamanaka Takuya¹,Takeshita Katsushi²,Mochizuki Takao¹,Inoue Hirokazu²,Akiyama Toru¹

Affiliation:

1. Department of Orthopaedic Surgery, Saitama Medical Center, Jichi Medical University

2. Department of Orthopaedic Surgery, School of Medicine, Jichi Medical University

Publisher

Japanese Society for Spine Surgery and Related Research

Subject

Neurology (clinical),Orthopedics and Sports Medicine,Surgery

Link

https://www.jstage.jst.go.jp/article/ssrr/7/2/7_2022-0127/_pdf

Reference16 articles.

1. 1. Baron R, Freynhagen R, Tölle TR, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain. 2010;150 (3):420-7.

2. 2. Igarashi A, Akazawa M, Murata T, et al. Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan. Clinicoecon Outcomes Res. 2015;7:505-20.

3. 3. Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1 (1):CD007076.

4. 4. Shimada Y, Inage K, Orita S, et al. Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin. Spine Surg Relate Res. 2017;1 (1):40-3.

5. 5. Kimura Y, Yamaguchi S, Suzuki T, et al. Switching from pregabalin to mirogabalin in patients with peripheral neuropathic pain: a multi-center, prospective, single-arm, open-label study (MIROP Study). Pain Ther. 2021;10 (1):711-27.